Insider Transactions in Q4 2024 at Viking Therapeutics, Inc. (VKTX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 08
2024
|
Lawson Macartney |
SELL
Open market or private sale
|
Direct |
2,000
-4.0%
|
$136,000
$68.67 P/Share
|
|
Nov 08
2024
|
Lawson Macartney |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+3.85%
|
$10,000
$5.8 P/Share
|
|
Oct 28
2024
|
Greg Zante Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
131,687
-7.46%
|
$10,271,586
$78.19 P/Share
|
|
Oct 28
2024
|
Greg Zante Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
94,001
+8.39%
|
$564,006
$6.69 P/Share
|
|
Oct 25
2024
|
J Matthew Singleton |
SELL
Open market or private sale
|
Direct |
16,000
-62.75%
|
$1,264,000
$79.5 P/Share
|
|
Oct 25
2024
|
J Matthew Singleton |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+38.55%
|
$64,000
$4.48 P/Share
|
|
Oct 25
2024
|
Sarah Kathryn Rouan |
SELL
Open market or private sale
|
Direct |
11,000
-100.0%
|
$880,000
$80.89 P/Share
|
|
Oct 25
2024
|
Sarah Kathryn Rouan |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+50.0%
|
$44,000
$4.88 P/Share
|